Cormorant Reports a $10 Million EYPT Purchase

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes via two Form 4 filings by Cormorant Asset Management.

The hedge fund reported a purchase of roughly $10 million in EyePoint Pharmaceuticals $EYPT.

Here’s The Hot Corner, with data through May 8, 2024:

The executive vice president and CFO along with one director of Penn National Gaming $PENN filed Form 4s revealing purchases for a total amount of $874,233.

In another Form 4, director Marston Becker revealed the acquisition of 3,025 shares, equivalent to $201,404, of AXIS Capital Holdings Limited $AXS.

Stay tuned. We’ll be back on Friday with more insider activity.

Sign up for The Hot Corner to have these insider transactions e-mailed to you every Monday through Friday.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

The post Cormorant Reports a $10 Million EYPT Purchase appeared first on All Star Charts.